• No results found

A new therapeutic advance for symptomatic systemic mastocytosis?

N/A
N/A
Protected

Academic year: 2022

Share "A new therapeutic advance for symptomatic systemic mastocytosis?"

Copied!
3
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

This report presented effects of cultural differences in individualism/collectivism, power distance, uncertainty avoidance, masculinity/femininity, and long term/short

Next, we present cryptographic mechanisms that we have found to be typically implemented on common commercial unmanned aerial vehicles, and how they relate to the vulnerabilities

An abstract characterisation of reduction operators Intuitively a reduction operation, in the sense intended in the present paper, is an operation that can be applied to inter-

The results indicate that the correlation between diagnostic accuracy of symptomatic patients tested with reverse transcription polymerase chain reaction (rRT-PCR) using

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.. Tavazzi L, Maggioni

There had been an innovative report prepared by Lord Dawson in 1920 for the Minister of Health’s Consultative Council on Medical and Allied Services, in which he used his

The build-up of child psychiatry as a clin- ical and academic discipline in Norway is mostly a post-World-War-II process, and in this book the story about it is told by two of

Cost–utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo- controlled trial in Norway (the